Valted Seq, Inc.

HIF-SEQ

Pharmaceuticals in the fields of neurodegenerative diseases, brain cancer, and brain tumors;Reagents, assays and cells for scientific or research use for development or manufacture of pharmaceuticals, diagnostics and therapeutics; Assays for research purposes; Biochemical reagents used for non-medical purposes; Diagnostic reagents for scientific or research use;

HIF-SEQ

Data processing services in the fields of custom chemistry, human disease diagnostics, and human therapeutics;Data analysis services for scientific research purposes in the fields of custom chemistry, human disease diagnostics, and human therapeutics;

HIF-SEQ

Research and development of pharmaceuticals for the treatment of neurodegenerative diseases, brain cancer, and brain tumors; providing information about medical research in the field of neurodegenerative diseases, brain cancer, and tumors; research and development in the pharmaceutical and biotechnology fields; Research and development services in the fields of custom chemistry, DNA sequencing and quantification, assay design, testing and analysis, bioinfomatics and biological data analysis, and biological image processing and data extraction, and consultation services related thereto;

HIF-SEQ

Medical testing services, namely, next generation sequencing tests for diagnosis, prognosis, and treatment of brain cancer and brain tumors; marking, separating, isolating, and sequencing and analysis of human tissue and human brain samples for diagnostic or treatment purposes;

HIF-SNRNASEQ

Pharmaceuticals in the fields of neurodegenerative diseases, brain cancer, and brain tumors;HIF SINGLE NUCLEUS RNA SEQUENCING, HIF SINGLE NUCLEI RNA SEQUENCING;Reagents, assays and cells for scientific or research use for development or manufacture of pharmaceuticals, diagnostics and therapeutics; Assays for research purposes; Biochemical reagents used for non-medical purposes; Diagnostic reagents for scientific or research use;

HIF-SNRNASEQ

Data processing services in the fields of custom chemistry, human disease diagnostics, and human therapeutics;Data analysis services for scientific research purposes in the fields of custom chemistry, human disease diagnostics, and human therapeutics;

HIF-SNRNASEQ

HIF SINGLE NUCLEUS RNA SEQUENCING, SINGLE NUCLEI RNA SEQUENCING;Research and development of pharmaceuticals for the treatment of neurodegenerative diseases, brain cancer, and brain tumors; providing information about medical research in the field of neurodegenerative diseases, brain cancer, and tumors; research and development in the pharmaceutical and biotechnology fields; Research and development services in the fields of custom chemistry, DNA sequencing and quantification, assay design, testing and analysis, bioinfomatics and biological data analysis, and biological image processing and data extraction, and consultation services related thereto;

HIF-SNRNASEQ

HIF SINGLE NUCLEUS RNA SEQUENCING, SINGLE NUCLEI RNA SEQUENCING;Medical testing services, namely, next generation sequencing tests for diagnosis, prognosis, and treatment of brain cancer and brain tumors; marking, separating, isolating, and sequencing and analysis of human tissue and human brain samples for diagnostic or treatment purposes;

VALTED SEQ

Reagents, assays and cells for scientific or research use for development or manufacture of pharmaceuticals, diagnostics and therapeutics; Assays for research purposes; Biochemical reagents used for non-medical purposes; Diagnostic reagents for scientific or research use; Medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurodegenerative diseases, brain cancer, and brain tumors; Pharmaceuticals in the fields of neurodegenerative diseases, brain cancer, and brain tumors;

VALTED SEQ

SEQ;Research and development of pharmaceuticals for the treatment of neurodegenerative diseases, brain cancer, and brain tumors; Research and development of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurodegenerative diseases, brain cancer, and brain tumors; Providing information about medical research in the field of neurodegenerative diseases, brain cancer, and tumors; research and development in the pharmaceutical and biotechnology fields;

VALTED SEQ

Medical testing services, namely, next generation sequencing tests for diagnosis, prognosis, and treatment of brain cancer and brain tumors; Medical testing services, namely, immunoassays, enzyme-linked immunosorbent (ELISA) assays for disease detection;